Skip to main content
. Author manuscript; available in PMC: 2021 Jan 3.
Published in final edited form as: Clin Gastroenterol Hepatol. 2018 Oct 26;17(8):1509–1514. doi: 10.1016/j.cgh.2018.10.035

Table 2.

Univariable Logistic Regression for Low aBMD-Z (<−2) at First and Second DXA Scans

First DXA (n = 673)
Second DXA (n = 108)
n Unadjusted OR (95% CI) P value n Unadjusted OR (95% CI) P value
Male (reference: female) 673 0.90 (0.48–1.69) .75 108 1.15 (0.30–4.34) .8
Age, y 673 1.02 (0.94–1.10) .67 108 1.15 (0.95–1.39) .2
BMI-Z at first DXA 669 0.46 (0.35–0.60) <.001a 108 0.83 (0.44–1.56) .6
BMI-Z at second DXA 106 0.85 (0.39–1.85) .7
Time from diagnosis (or prior DXA), d 673 1.00 (0.99–1.00) .7 108 1.00 (1.00–1.00) .4
Vitamin D, ng/mL 559 1.02 (1.00–1.05) .1 97 1.00 (0.96–1.06) .9
Albumin, g/dL 505 0.70 (0.30–1.63) .4 96 9.14 (0.54–153.9) .1
Alkaline phosphatase, U/L 505 1.00 (1.00–1.00) .2 96 1.00 (1.00–1.01) .3
Hemoglobin, g/dL 516 1.10 (0.79–1.54) .6 98 1.05 (0.53–2.08) .9
Calcium, mg/dL 507 1.14 (0.46–2.78) .8 97 1.99 (0.27–14.8) .5
Phosphorus, mg/dL 43 0.87 (0.30–2.49) .8 7 1.62 (0.22–11.7) .6
tTG, U 460 1.01 (1.00–1.02) .06 52 1.01 (1.00–1.03) .1
tTG IgA, U/mL 329 0.98 (0.96–1.00) .1 62 1.02 (0.99–1.05) .2
Baseline aBMD-Z 108 0.22 (0.11–0.50) <.001a

tTG, tissue transglutaminase.

a

P < .05.